Sinopharm Partners With UK TB Vaccine Firm

BMI View: Sinopharm has very strong research and development (R&D) capabilities given that it has six subsidiaries focusing on the introduction of innovative biopharmaceutical products. However, in order to continue its outperformance against competitors, it is essential that the firm develops vaccines against other diseases.

To read the full article, please choose one of the following options: